Christopher Ocampo
Head of Psychiatry, Neuroscience Clinical Development Abbvie
I have been at AbbVie since 2013 having spent the majority of my time in Clinical Development across various therapeutic areas including Solid Tumor Oncology, Immunology, General Medicine/Virology and Neuroscience. Since joining the Neuroscience group in 2023 I have worked on assets in neurodegeneration and psychiatry and became Head of Psychiatry Clinical Development in 2025.
Seminars
Thursday 10th December 2026
An Overview of AbbVie’s Diverse Neuropsychiatry Pipeline
2:00 pm
- Reviewing AbbVie’s abundant pipeline spanning a range of assets in mood disorders
- Highlighting AbbVie’s priorities and commitment to advancing treatments in MDD, BPD and Schizophrenia
- General overview of programs in Neurology, Neurodegeneration, Migraine and Pain
